MedTrace Logo

Biomarkers in Prediction of AMI

NCT06212921 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2024-12-03

No results posted yet for this study

Summary

Current study will be undertaken to identify combinations of biomarkers that can reliably identify acute mesenteric ischaemia (AMI) and distinguish between non-transmural and transmural ischaemia. Different combinations of biomarkers for different sub-types and severity of AMI, and different time points of measurement after onset of symptoms.

Conditions

  • Acute Mesenteric Ischemia

Interventions

DIAGNOSTIC_TEST

Sequential blood samples

Sequential blood samples for diagnostic tests is the only intervention in thei study

Sponsors & Collaborators

  • University of Tartu

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-14
Primary Completion
2025-09-30
Completion
2025-12-31

Countries

  • Estonia
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06212921 on ClinicalTrials.gov